Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 475 - Heterocyclic compounds containing pteridine ring systems
Patents for C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
06/2000
06/20/2000CA1341034C Heterocyclic 2-alkoxyphenoxysulfonylureas and the use thereof as herbicides or plant growth regulators
06/15/2000WO2000034281A1 Methotrexate derivatives
06/15/2000CA2353839A1 Methotrexate derivatives
06/14/2000EP1007533A1 Bioconjugates and delivery of bioactive agents
06/14/2000EP1007042A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
06/08/2000WO1999066063A9 Nucleosidic and non-nucleosidic folate conjugates
06/07/2000EP1005356A1 Novel antibacterial agents
05/2000
05/31/2000EP1004308A1 Preventives or remedies for drug-induced renal disturbance
05/31/2000EP1003541A1 Inhibitors of hiv reverse transcriptase
05/30/2000CA2031784C Process for the preparation of optically pure diastereoisomers of tetrahydrofolate compounds
05/30/2000CA1341007C Alkyl- and alkenylsulfonylureas which are substituted in the heterocycle, processes for their preparation, and their use as herbicides or plant growth regulators
05/11/2000WO2000025764A2 Compositions for the treatment and prevention of cardiovascular diseases
05/04/2000WO1999063988A9 Inhibitors of nitric oxide synthase
04/2000
04/27/2000WO2000023448A1 Novel pterin antineoplastic agents
04/26/2000EP0995749A1 Process for purification and crystallisation of riboflavin
04/26/2000EP0994717A1 Treatment of autoimmune disease using tolerization in combination with methotrexate
04/26/2000CN1251365A Method for purifying and crystallizing vitamin B2
04/20/2000WO1999066063A3 Nucleosidic and non-nucleosidic folate conjugates
04/19/2000CA2282908A1 Purification and crystallization process for riboflavin
04/05/2000EP0989857A1 Novel therapeutic agents that modulate enzymatic processes
03/2000
03/22/2000EP0986561A1 Compounds for inhibition of ceramide-mediated signal transduction
03/16/2000WO1999064047A9 Novel antiviral compounds
03/16/2000WO1999063929A9 Multibinding inhibitors of microsomal triglyceride transferase protein
03/08/2000EP0983765A1 Preventives or remedies for diseases in association with vascular functional anomaly relating to insulin resistance
03/02/2000WO2000010983A1 Process for preparing regiospecific substituted pyrazine isomers
03/02/2000WO1999064054A9 Multibinding inhibitors of topoisomerase
03/02/2000WO1999063937A3 Multivalent macrolide antibiotics
03/02/2000CA2340250A1 Process for preparing regiospecific substituted pyrazine isomers
02/2000
02/22/2000US6028071 Purified compositions of 10-propargyl-10-deazaaminopterin and methods of using same in the treatment of tumors
02/10/2000WO2000006585A1 Medicine nitrate salts
02/10/2000WO1999063939A3 Multibinding inhibitors of cyclooxygenase-2
02/10/2000CA2338912A1 Medicine nitrate salts
02/09/2000EP0977725A1 New fatty acid derivatives
02/03/2000WO1999063929A3 Multibinding inhibitors of microsomal triglyceride transferase protein
01/2000
01/25/2000US6018048 Noble metal Raney catalysts and preparation of hydrogenated compounds therewith
01/06/2000WO2000000491A1 Bifunctional antagonists of cytokine-sensitive protein kinase activation cascades and methods for use as anti-inflammatory agents
01/06/2000CA2335595A1 Bifunctional antagonists of cytokine-sensitive protein kinase activation cascades and methods for use as anti-inflammatory agents
01/05/2000EP0968179A1 N-sulphonyl and n-sulphinyl amino acid amides as microbiocides
01/04/2000US6011040 Use of tetrahydrofolates in natural stereoisomeric form for the production of a pharmaceutical preparation suitable for influencing the homocysteine level, particularly for assisting the remethylation of homocysteine
12/1999
12/29/1999CN1239949A Novel heterocyclically substituted benzamides and their use in fighting diseases
12/28/1999CA2010980C Processes for the preparation of pterin derivatives
12/23/1999WO1999066063A2 Nucleosidic and non-nucleosidic folate conjugates
12/21/1999US6004966 Use of xanthine oxidase inhibitors as anti-ischaemic agents
12/16/1999WO1999064054A1 Multibinding inhibitors of topoisomerase
12/16/1999WO1999064051A1 Novel antibacterial compounds
12/16/1999WO1999064049A1 Novel antibacterial agents
12/16/1999WO1999064048A1 Inhibitors of hiv reverse transcriptase
12/16/1999WO1999064047A1 Novel antiviral compounds
12/16/1999WO1999064037A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999WO1999064033A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999WO1999064032A1 Combinatorial synthesis of multibinding libraries
12/16/1999WO1999063994A1 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE
12/16/1999WO1999063988A1 Inhibitors of nitric oxide synthase
12/16/1999WO1999063940A2 INHIBITORS OF H+K+-ATPase
12/16/1999WO1999063939A2 Multibinding inhibitors of cyclooxygenase-2
12/16/1999WO1999063937A2 Multivalent macrolide antibiotics
12/16/1999WO1999063929A2 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999CA2321274A1 Novel antiviral compounds
12/16/1999CA2321190A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999CA2321166A1 Multibinding inhibitors of topoisomerase
12/16/1999CA2321162A1 Novel antibacterial compounds
12/16/1999CA2320290A1 Multibinding inhibitors of cyclooxygenase-2
12/16/1999CA2320241A1 Multivalent macrolide antibiotics
12/16/1999CA2319761A1 Multibinding inhibitors of hmg-coa reductase
12/16/1999CA2319495A1 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999CA2319477A1 Inhibitors of h+k+-atpase
12/16/1999CA2319474A1 Inhibitors of nitric oxide synthase
12/16/1999CA2319120A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999CA2318547A1 Combinatorial synthesis of multibinding libraries
12/16/1999CA2316999A1 Inhibitors of hiv reverse transcriptase
12/08/1999EP0543997B1 Derivatives of methotrexate with antirheumatic activity
11/1999
11/10/1999CN1046285C Condensed heterocyclic glutamic acid derivatives as antiproliferative agents
11/02/1999US5976844 Riboflavin-production process by means of micro-organisms with modified isocitratlyase activity
10/1999
10/27/1999EP0951842A2 Infant formula
10/21/1999WO1999052861A1 Novel benzyl guanidine derivatives for therapy and in-vivo and in-vitro diagnosis
10/20/1999EP0635006B1 Europium and terbium chelators for time-resolved fluorometric assays
10/14/1999WO1999051572A1 Sulfonamide derivatives
10/14/1999DE19817517A1 New benzylguanidine derivatives useful for diagnosis or therapy, especially of neuroblastoma
10/14/1999CA2327290A1 Sulfonamide derivatives
10/06/1999EP0946509A1 Novel heterocyclically substituted benzamides and their use in fighting diseases
10/05/1999US5962457 2,3 Disubstituted- (5,6)-heteroarylfused-pyrimidine-4-ones
09/1999
09/29/1999EP0944389A1 Purified compositions of 10-propargyl-10-deazaaminopterin and methods of using same in the treatment of tumors
09/28/1999US5958928 Pharmaceutical agents containing methotrexate derivative
09/22/1999CN1045206C Method for preparing cyclic amide derivative
09/15/1999EP0676399B1 Methotrexate derivatives
09/15/1999CN1228701A Heterocyclic compounds with thrombolytic activity and their use for treating thrombosis
09/14/1999US5952499 Therapeutic compound-fatty acid conjugates
09/08/1999CN1228091A Substituted 6,6-hetero-bicyclic derivatives
09/02/1999WO1999043325A1 Preventives or remedies for diseases in association with vascular functional anomaly relating to insulin resistance
09/02/1999WO1999043324A1 Preventives or remedies for drug-induced renal disturbance
09/01/1999CN1227553A Bicyclic pyrimidine derivatives and their use as anti-coagulants
08/1999
08/31/1999US5945420 Immunopotentiating and infection protective agent and production thereof
08/12/1999WO1999040089A1 Benzothiadiazoles and derivatives
08/12/1999WO1999026940A3 Method for producing 8-methoxy-quinoline carboxylic acids
08/12/1999CA2318977A1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines
08/11/1999EP0934920A2 Preparation of hydrogenated compounds using noble metal Raney catalysts
08/11/1999EP0934363A1 Process for colouring high molecular weight organic material and polycyclic pigments
08/04/1999CN1044427C Method for weeding using 2-alkoxy phenoxy sulfonylurea with heterocycle as herbicides
07/1999
07/27/1999US5929046 Pyrimidine and purine derivatives and their use in treating tumour cells
07/21/1999EP0929551A1 New pharmaceutically active compounds
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28